Today’s issue of WorkCompRecap features a petition recently filed with the U.S. FDA by a broad coalition of doctors, researchers and public health officials regarding the labeling of opioids. According to the petition, current opioid labels, which simply state that they are approved for “moderate to severe pain”, are overly broad because they fail to limit use to severe pain, include a time frame for use, and specify a maximum dose.
The petition contains specific change requests geared toward when opioids are used for non-cancer pain, including striking the use of “moderate”, adding a suggested maximum dose equivalent to 100 mg of morphine, and adding a suggested duration of use. The petition’s co-signers believe that preventing aggressive promotion of opioids for moderate pain will help curtail overprescribing.
Find out more by clicking here!